发布求助
文献互助 智能选刊 最新文献

Expert Review of Dermatology最新文献

筛选
英文 中文
Clinical challenges and recent advances in the diagnosis of bullous pemphigoid 大疱性类天疱疮诊断的临床挑战和最新进展
Expert Review of Dermatology Pub Date : 2013-08-01 DOI: 10.1586/17469872.2013.816497
S. Tambe, S. Häfliger, L. Borradori
{"title":"Clinical challenges and recent advances in the diagnosis of bullous pemphigoid","authors":"S. Tambe, S. Häfliger, L. Borradori","doi":"10.1586/17469872.2013.816497","DOIUrl":"https://doi.org/10.1586/17469872.2013.816497","url":null,"abstract":"Bullous pemphigoid (BP) is an autoimmune subepidermal blistering disease associated with autoantibodies directed against two components of junctional adhesion complexes in stratified epithelia, BPAG2 and BPAG1-e. BP typically develops in the elderly and manifests with widespread eczematous, urticated and bullous lesions. In up to 20% of the affected patients, obvious blistering is lacking and the clinical features of BP are misleading and closely mimic a variety of other inflammatory conditions. Diagnosis of BP, which should be rather called cutaneous pemphigoid, relies on direct immunofluorescence microscopy studies to detect tissue-bound IgG and/or C3 immune deposits along the epidermal basement membrane zone. Here, the clinical presentations of BP and the diagnostic algorithm with the immunopathological studies available to classify affected patients are reviewed. Finally, the need for widely accepted criteria for the classification of BP patients is emphasized, since in a number of patients with featu...","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90672498","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Efinaconazole 10% solution: a new topical antifungal therapy for onychomycosis 10%艾非那康唑溶液:一种治疗甲真菌病的新型局部抗真菌药物
Expert Review of Dermatology Pub Date : 2013-08-01 DOI: 10.1586/17469872.2013.814872
B. Elewski
{"title":"Efinaconazole 10% solution: a new topical antifungal therapy for onychomycosis","authors":"B. Elewski","doi":"10.1586/17469872.2013.814872","DOIUrl":"https://doi.org/10.1586/17469872.2013.814872","url":null,"abstract":"Onychomycosis is a common nail infection for which treatment options are limited, and no new treatment have been introduced for over 10 years. While patients might prefer a topical therapy, efficacy with ciclopirox and amorolfine lacquers has been disappointing especially in moderate to severe disease. Efinaconazole 10% solution is a new triazole antifungal, specifically developed for the topical treatment of onychomycosis. Its physicochemical properties, antifungal activity and formulation are all important aspects of the development program and are reviewed here. Efinaconazole 10% solution may provide the first viable alternative to oral therapy for onychomycosis. Mycologic cure rates are comparable to those seen with oral itraconazole, and greater than reported with ciclopirox lacquer.","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85445430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Challenges involved in the diagnostic interpretation of FISH for melanocytic neoplasms 在黑素细胞肿瘤的FISH诊断解释中涉及的挑战
Expert Review of Dermatology Pub Date : 2013-08-01 DOI: 10.1586/17469872.2013.814861
Chelsea Cooper, L. Sholl, P. Gerami
{"title":"Challenges involved in the diagnostic interpretation of FISH for melanocytic neoplasms","authors":"Chelsea Cooper, L. Sholl, P. Gerami","doi":"10.1586/17469872.2013.814861","DOIUrl":"https://doi.org/10.1586/17469872.2013.814861","url":null,"abstract":"At the molecular level, melanoma and nevi exhibit distinct chromosomal copy number aberrations. As a result, the addition of molecular techniques such as FISH may improve the diagnostic procedures for melanocytic neoplasms. FISH probes targeting 6p25, 11q13, 6q23, 9p21, 8q24 and CEP 6 are currently used in the diagnosis of melanoma. While these assays can be of great utility, there are challenges that may emerge in optimizing interpretation. In this review, the authors discuss technical challenges commonly associated with the FISH protocol such as overdigestion, underdigestion and excessive background. The authors also present challenges associated with interpretation of the FISH for chromosomal copy number changes and offer suggestions as to how the effects of these difficulties can be minimized.","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89211214","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Etanercept for the treatment of psoriasis 依那西普用于治疗牛皮癣
Expert Review of Dermatology Pub Date : 2013-08-01 DOI: 10.1586/17469872.2013.814880
M. Ara, E. Daudén
{"title":"Etanercept for the treatment of psoriasis","authors":"M. Ara, E. Daudén","doi":"10.1586/17469872.2013.814880","DOIUrl":"https://doi.org/10.1586/17469872.2013.814880","url":null,"abstract":"Etanercept is a systemic tumor necrosis factor-α inhibitor indicated for use in the treatment of rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis and plaque psoriasis. A considerable number of studies have demonstrated the efficacy and safety of etanercept in these indications, thus offering a new and promising treatment option. The drug was approved by the Food and Drug Administration in the United States and by the European Medicines Evaluation Agency in Europe for treating moderate-to-severe psoriasis in 2004. This article reviews the pharmacology, clinical efficacy and safety of etanercept for psoriasis and recent findings since its approval. The number of studies of medium- and long-term efficacy and safety is increasing steadily; these studies support the use of etanercept in a maintenance setting, with an apparently more favorable risk: benefit ratio than traditional systemic treatments.","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82780947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Managing mycetoma: guidelines for best practice 足菌肿管理:最佳实践指南
Expert Review of Dermatology Pub Date : 2013-06-01 DOI: 10.1586/EDM.13.31
A. Fahal, A. Elkhawad
{"title":"Managing mycetoma: guidelines for best practice","authors":"A. Fahal, A. Elkhawad","doi":"10.1586/EDM.13.31","DOIUrl":"https://doi.org/10.1586/EDM.13.31","url":null,"abstract":"Mycetoma is a serious health problem that is endemic in many tropical and subtropical regions and characterized by devastating deformities, disability and high morbidity. It is a badly neglected disease worldwide. To date, mycetoma’s true incidence, prevalence and route of infection are not well understood; likewise, its susceptibility, resistance and response to medical treatment, which negatively affects patient management. Current treatment, in particular for eumycetoma, has proven to be quite ineffective, have serious side effects and is expensive for patients and health authorities in endemic areas. In general, the eumycetoma treatment outcome is disappointing and is associated with a low cure rate and high amputation and recurrence rates. Late patient presentation is a major problem in mycetoma due to the lack of health education, poor patient socioeconomic status and poor treatment compliance. This is aggravated by a lack of national and international disease awareness, which has led to a massive k...","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81396649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Developments into understanding the pathogenesis of systemic sclerosis 系统性硬化症发病机制的研究进展
Expert Review of Dermatology Pub Date : 2013-06-01 DOI: 10.1586/EDM.13.8
N. Hunzelmann
{"title":"Developments into understanding the pathogenesis of systemic sclerosis","authors":"N. Hunzelmann","doi":"10.1586/EDM.13.8","DOIUrl":"https://doi.org/10.1586/EDM.13.8","url":null,"abstract":"Systemic sclerosis (SSc) is a severe, chronic autoimmune disease of the connective tissue. The disease typically becomes clinically apparent on the skin and subsequently spreads to several internal organs, in particular the gastrointestinal system, lung, heart and kidney (in decreasing frequency). The pathogenesis evolves via activation of the vascular and immune system, finally leading to a fibrotic response of the connective tissue and resulting in progressive dysfunction of the affected organs. Although the etiology still remains elusive, the knowledge of genetic factors associated with SSc has increased remarkably in recent years. It can be shown that SSc shares a number of genetic risk factors with other autoimmune diseases, in particular lupus erythematosus. New pathways such as Wnt signaling have been identified, which improve our understanding of the initiation of fibrosis in this still enigmatic disease. The enhanced insight into distinct steps of the organotypic pathophysiology of SSc, for examp...","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78226581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hormonal acne: leading to a paradigm shift in the management of acne 荷尔蒙痤疮:导致痤疮管理的范式转变
Expert Review of Dermatology Pub Date : 2013-06-01 DOI: 10.1586/EDM.13.21
Jayakar Thomas, K. Parimalam, R. Sindhu
{"title":"Hormonal acne: leading to a paradigm shift in the management of acne","authors":"Jayakar Thomas, K. Parimalam, R. Sindhu","doi":"10.1586/EDM.13.21","DOIUrl":"https://doi.org/10.1586/EDM.13.21","url":null,"abstract":"","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"81618001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Comorbidities of psoriasis 牛皮癣的合并症
Expert Review of Dermatology Pub Date : 2013-06-01 DOI: 10.1586/EDM.13.23
S. Churton, Kristen Doud, N. Korman
{"title":"Comorbidities of psoriasis","authors":"S. Churton, Kristen Doud, N. Korman","doi":"10.1586/EDM.13.23","DOIUrl":"https://doi.org/10.1586/EDM.13.23","url":null,"abstract":"Psoriasis is a chronic, immune-mediated inflammatory skin disease that is associated with multiple comorbidities including psoriatic arthritis, cardiometabolic diseases, malignancies, nonalcoholic fatty liver disease, autoimmune diseases, inflammatory-bowel disease, obstructive sleep apnea and chronic obstructive pulmonary disease. Cardiovascular disease including myocardial infarction, stroke and subclinical atherosclerosis as well as obesity, metabolic syndrome, diabetes, hypertension and hyperlipidemia, are associated with psoriasis. Shared inflammatory pathways may be the basis for these disease associations, especially in the case of cardiovascular disease and its risk factors. Reduced quality of life, depression, anxiety, smoking and alcoholism are also seen in psoriasis patients. Awareness and understanding of the relationships between psoriasis and its comorbidities is important in managing patients with psoriasis. The multiple comorbidities associated with psoriasis will be discussed here, focusi...","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86562231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Mycosis fungoides in children and adolescents 儿童和青少年蕈样真菌病
Expert Review of Dermatology Pub Date : 2013-06-01 DOI: 10.1586/EDM.13.29
A. Nanda, H. Al-Ajmi
{"title":"Mycosis fungoides in children and adolescents","authors":"A. Nanda, H. Al-Ajmi","doi":"10.1586/EDM.13.29","DOIUrl":"https://doi.org/10.1586/EDM.13.29","url":null,"abstract":"Mycosis fungoides (MF) is a low-grade lymphoproliferative disorder that is histologically characterized by an epidermotropic proliferation of small or medium-sized atypical T lymphocytes with cerebriform nuclei and is primarily a disease of the elderly. It is rare in children and adolescents; in large series of MF published in the literature, only a small percentage of patients were observed to have onset of MF below adolescence. It was believed that a younger age of onset of MF may herald a poorer prognosis. Recently, with improved knowledge of the basic nature of the disease and refined diagnostic facilities, a few series of MF among children and adolescence have appeared and have drawn more awareness to the behavior of MF in this age group. This review summarizes the clinicoepidemiological features, treatment and prognosis of MF among children and adolescents based on the current literature.","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77291995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Should there be an app for that? Controversies of diagnosing melanoma with your smartphone 应该有这样的应用吗?用智能手机诊断黑色素瘤的争议
Expert Review of Dermatology Pub Date : 2013-06-01 DOI: 10.1586/EDM.13.22
J. F. Moreau, L. Ferris
{"title":"Should there be an app for that? Controversies of diagnosing melanoma with your smartphone","authors":"J. F. Moreau, L. Ferris","doi":"10.1586/EDM.13.22","DOIUrl":"https://doi.org/10.1586/EDM.13.22","url":null,"abstract":"","PeriodicalId":12255,"journal":{"name":"Expert Review of Dermatology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2013-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"78461672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信